SVT
5
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
10 treatments under study, led by Rivaroxaban
Research Leaders
7 sponsors active, led by Royal Devon and Exeter NHS Foundation Trust
Related Conditions
Often studied with 8 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT
A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
Differentiate AVNRT from Orthodromic AVRT
Testing of a Valsalva Assist Device (VAD) in Healthy Volunteers Performing a Valsalva Manoeuvre
Evaluation of the Valsalva Assist Device to Treat SVT
Research Network
Common Treatments
- Rivaroxaban1
- Catheter Ablation1
- Standard Care1
- Modified Vm Vad1
- Modified Vm Manonmeter1
Active Sponsors
- Royal Devon and Exeter NHS Foundation Trust2
- South Western Ambulance Service NHS Foundation Trust1
- University of Exeter1
- Ottawa Hospital Research Institute1
- Assiut University1
Top Investigators
Ottawa Hospital Research Institute
Assiut University
Royal Devon and Exeter NHS Foundation Trust
Assiut University
Royal Devon and Exeter NHS Foundation Trust
Related Conditions
- Vagal Bradycardia2
- Psvt1
- Superficial Vein Thrombosis1
- Supraventricular Arrhythmia1
- Emergencies1